INTEGRATED healthcare operator IHH Healthcare on Thursday (Feb 27) announced net profit of RM732 million (S$221 million) for the quarter ended Dec 31, 2024, up 1 per cent from RM728 million in the corresponding year-ago period.
This translates to earnings per share (EPS) of RM0.0831, compared to RM0.0826 in the fourth quarter of 2023.
The group declared a final dividend per share of RM0.055, to be paid on Apr 28.
This brings the total dividend per share for FY2024 to RM0.10, compared to RM0.09 in FY2023.
Revenue for the period gained 26 per cent on-year to RM6.7 billion, from RM5.3 billion.
This was due to a sustained demand for quality healthcare services, higher inpatient volumes as well as revenue intensity from taking on more complex cases, said IHH Healthcare.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
The consolidation of Timberland Medical Centre and Island Hospital upon acquisition also contributed to the increase in revenue.
On a full-year basis, profit declined 10 per cent year on year to RM2.7 billion, from about RM3 billion a year ago. This was attributed to the absence of the one-off gains from the sale of International Medical University and Gleneagles Hospital Chengdu in FY2023, which amounted to RM989 million
Revenue for the year increased 16 per cent year on year to RM24.4 billion, from RM20.9 billion.
Commenting on the outlook, Dr Prem Nair, IHH Healthcare’s group chief executive, said: “The favourable secular trends in our key markets provide strong tailwinds for our continued growth. We are confident in strengthening our position as a global healthcare leader while delivering healthy returns to our shareholders.”
Shares of IHH Healthcare declined 2.3 per cent or S$0.05 to S$2.15, before the announcement.
Copyright SPH Media. All rights reserved.
